# All the latest from Verge

Read our most recent News, Publications, and Blog posts.

## News - June 17, 2026
**STAT News: “Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials”**  
Verge’s CEO, Alice Zhang, and Head of Product & Engineering, Emily Ripka, spoke to STAT News about the release of vBx-1.0, the company’s breakthrough foundation model for precision neurology.  
[Read more](https://www.statnews.com/2026/06/16/verge-labs-ai-model-clinical-trials-data-neurology-diseases/)

## News - June 16, 2026
**Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology**  
By Verge Labs  
[Read more](https://vergelabs.com/resources/news/vbx-launch/)

## Report - June 16, 2026
**Introducing vBx-1.0**  
By Verge Labs  
[Read more](https://vergelabs.com/resources/reports/vbx-one-technical-report/)

## News - June 9, 2026
**Verge Labs and Tenacia Biotechnology Partner to Advance Tenacia’s CNS Pipeline Using Human Data**  
By Verge Labs  
[Read more](https://vergelabs.com/resources/news/tenacia-cns-partnership/)

## Blog - May 27, 2026
**Why We’re Becoming Verge Labs**  
By Alice Zhang  
[Read more](https://www.vergelabs.blog/p/why-were-becoming-verge-labs)

## Blog - May 27, 2026
**What We Learned From The Trial of Our First AI-Discovered Drug**  
By Alice Zhang  
[Read more](https://www.vergelabs.blog/p/what-we-learned-from-the-trial-of)

## Publication - February 1, 2026
**Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635**  
By Gontier G, Kim G + 17 more  
[Read more](https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.70489)

## News - April 7, 2025
**Digital biomarkers detect short-term ALS progression in VRG50635 trial run-in**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/digital-biomarkers-vrg50635/)

## News - November 20, 2024
**Lilly selects two ALS targets from CONVERGE® collaboration**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/lilly-milestones-2024/)

## Publication - January 1, 2024
**Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution**  
By Martirosyan A, Ansari R + 14 more  
[Read more](https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-023-00699-0)

## News - November 29, 2023
**VRG50635 proof-of-concept study initiated in patients with ALS**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/vrg50635-poc-initiation/)

## News - October 31, 2023
**Verge Genomics and the Pritzker Consortium form schizophrenia research collaboration**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/pritzker-schizophrenia/)

## News - September 8, 2023
**Verge Genomics and Alexion launch AI-enabled drug discovery collaboration for rare neuro diseases**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/alexion-collaboration/)

## News - June 15, 2023
**Positive Phase 1 safety and tolerability data for VRG50635**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/vrg50635-phase1-safety/)

## Publication - December 1, 2022
**Single-nucleus co-expression networks of dopaminergic neurons support iron accumulation as a plausible explanation to their vulnerability in Parkinson’s disease**  
By Gómez-Pascual A, Martirosyan A + 12 more  
[Read more](https://www.biorxiv.org/content/10.1101/2022.12.13.514863v1)

## News - November 14, 2022
**Alice Zhang named to Fortune 40 Under 40 and Fierce Biotech’s Fiercest Women in Life Sciences**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/alice-zhang-fortune-fierce/)

## News - October 31, 2022
**First-in-human dosing of VRG50635 begins in Phase 1 trial**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/vrg50635-first-in-human/)

## News - October 12, 2022
**Alice Zhang honored by Goldman Sachs as one of 2022’s Most Exceptional Entrepreneurs**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/goldman-sachs-honor/)

## News - September 12, 2022
**Fierce Biotech names Verge Genomics a 2022 “Fierce 15” biotech company**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/fierce-15-2022/)

## Publication - February 1, 2022
**Systematic comparative analysis of strand-specific RNA-seq library preparation methods for low input samples**  
By Naphade S, Bhatnagar R + 3 more  
[Read more](https://doi.org/10.1038/s41598-021-04583-z)

## News - July 8, 2021
**Verge Genomics and Eli Lilly announce three-year ALS collaboration**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/lilly-collaboration-2021/)

## News - October 5, 2020
**New approach for uncovering novel drug targets from human genetics published in PLOS Computational Biology**  
By Verge Genomics  
[Read more](https://vergelabs.com/resources/news/bagea-publication/)

## Publication - June 1, 2020
**A framework for integrating directed and undirected annotations to build explanatory models of cis-eQTL data**  
By Lamparter D, Bhatnagar R + 4 more  
[Read more](https://journals.plos.org/ploscompbiol/article?id=10.1371%2Fjournal.pcbi.1007770)

## Publication - February 1, 2018
**Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons**  
By Shi Y, Lin S + 7 more  
[Read more](https://www.nature.com/articles/nm.4490)